LetterSkin cancer, photoprotection, and skin of color
References (2)
- et al.
Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public
J Am Acad Dermatol
(2014) - et al.
The epidemiology of UV induced skin cancer
J Photochem Photobiol B
(2001)
Cited by (9)
Exploration of anticancer potential of Lantadenes from weed Lantana camara: Synthesis, in silico, in vitro and in vivo studies
2023, PhytochemistryCitation Excerpt :Cancer is a generic term for large group of disease and involves the rapid formation of abnormal cells with the tendency to invade adjoining tissues and organs, called metastasis (Jiang et al., 2015; Wittekind and Neid, 2005). So far 600 plus types of cancer have been claimed by International Classification of Diseases-11, and skin cancer has remained as one of the most common malignant neoplasms in fair-skinned populations (Hiatt and Beyeler, 2020; Gupta et al., 2016; Dadzie et al., 2014) According to the estimates from Global Cancer Observatory (GLOBOCAN), almost 19.3 million new cancer cases and around 10.0 million cancer deaths has turned out in 2020. Significant increase in the global cancer burden is expected to be 28.4 million cases by the 2040, i.e. approximately double the rise in digits from 2020 (Sung et al., 2021).
Skin cancer in women of color: Epidemiology, pathogenesis and clinical manifestations
2021, International Journal of Women's DermatologyCitation Excerpt :Malignant melanoma (MM) and nonmelanoma skin cancers (NMSC), which include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), account for 40% of all neoplasms in white patients, making these the most common malignancy in the United States (Dadzie et al., 2014).
Prevention of skin cancer in "people of color": Let's be clear!
2015, Annales de Dermatologie et de VenereologieSun Exposure and Black Skin
2021, Current Problems in Dermatology (Switzerland)Modulation of Diacylglycerol-Induced Melanogenesis in Human Melanoma and Primary Melanocytes: Role of Stress Chaperone Mortalin
2019, Evidence-based Complementary and Alternative Medicine
Funding sources: None.
Disclosures: Dr Ophelia E. Dadzie has received research sponsorship funding from L'Oréal. She served as a speaker for Beiersdorf and Stiefel, a GSK company for which she received honoraria, and she is the founder and director of London Ethnic Skin Limited; Professor Nina G. Jablonski serves on the scientific advisory board of L'Oréal and served as a speaker for LVMH for which she received honoraria. The other authors declared no conflicts of interest.